Artificial intelligence in rheumatoid arthritis: current status and future perspectives: a state-of-the-art review

S Momtazmanesh, A Nowroozi, N Rezaei - Rheumatology and Therapy, 2022 - Springer
Investigation of the potential applications of artificial intelligence (AI), including machine
learning (ML) and deep learning (DL) techniques, is an exponentially growing field in …

Mendelian randomization reveals interactions of the blood proteome and immunome in mitral valve prolapse

LH Minvielle Moncla, M Briend… - Communications …, 2024 - nature.com
Background Mitral valve prolapse (MVP) is a common heart disorder characterized by an
excessive production of proteoglycans and extracellular matrix in mitral valve leaflets. Large …

An Assessment of Comparative Medication Durability in Inflammatory Bowel Disease Patients With and Without Co-morbid Psoriasis, Rheumatoid Arthritis, and/or …

K Cushing, JE Gudjonsson, E Speliotes… - Digestive diseases and …, 2023 - Springer
Background Patients with inflammatory bowel disease (IBD) are at increased risk for many
co-morbid diseases. However, little is known about durability of IBD medications in patients …

Systemic lupus in the era of machine learning medicine

K Zhan, KA Buhler, IY Chen, MJ Fritzler… - Lupus Science & …, 2024 - lupus.bmj.com
Artificial intelligence and machine learning applications are emerging as transformative
technologies in medicine. With greater access to a diverse range of big datasets …

Inflammatory bowel disease therapy: beyond the immunome

C Fiocchi, D Iliopoulos - Frontiers in Immunology, 2022 - frontiersin.org
Inflammation is the most common biological occurrence in any living organism's life, and it
can be both beneficial and harmful. Under homeostatic conditions inflammation is finely …

Enrichment of sars-Cov-2 entry factors and interacting intracellular genes in tissue and circulating immune cells

A Devaprasad, A Pandit - Viruses, 2021 - mdpi.com
SARS-CoV-2 uses ACE2 and TMPRSS2 to gain entry into the cell. However, recent studies
have shown that SARS-CoV-2 may use additional host factors that are required for the viral …

Lifitegrast, a Lymphocyte Function‐Associated Antigen‐1 Antagonist Demonstrates Beneficial Effect in Psoriasis

RS Gawande, L Rao Thakkalapally… - Drug Development …, 2024 - Wiley Online Library
Lifitegrast is a lymphocyte function‐associated antigen‐1 (LFA‐1) antagonist, which is
approved for treatment of dry eye disease. In this work we explored the effect of lifitegrast in …

[HTML][HTML] In Search of Predictive Indicators for the Development of Psoriatic Arthritis in Patients with Cutaneous Psoriasis: The Path Traversed and the Road Ahead

M Shastri, G Wahengbam, M Arora, P Pandey… - Journal of Skin and … - brieflands.com
Context: Psoriatic arthritis (PsA), a seronegative, irreversible inflammatory arthritis, displays
a heterogeneous clinical presentation that frequently impedes early detection of PsA …

[引用][C] About the Project

I Udalova